MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3324/haematol.10337

Медицинская библиотека · Haematologica · 2007

Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.

Ripperger Tim, von Neuhoff Nils, Kamphues Kathrin, Emura Makito, Lehmann Ulrich, Tauscher Marcel, Schraders Margit, Groenen Patricia, Skawran Britta, Rudolph Cornelia, Callet-Bauchu Evelyne, van Krieken Johan H J M, Schlegelberger Brigitte, Steinemann Doris

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVES

Mantle cell lymphoma (MCL), a mature B-cell neoplasm, is genetically characterized by the translocation t(11;14)(q13;q32). However, secondary alterations are required for malignant transformation. The identification of inactivated tumor suppressor genes contributing to the development of MCL may lead to further elucidation of the biology of this disease and help to identify novel targets for therapy.

DESIGN AND

METHODS

Whole genome microarray-based gene expression profiling on treated versus untreated MCL cell lines was used to identify genes induced by 5-aza-2'-deoxycytidine. The degree of promoter methylation and transcriptional silencing of selected genes was then proven in MCL cell lines and primary cases by methylation-specific polymerase chain reaction (PCR) techniques, real-time PCR and gene expression profiling.

RESULTS

After 5-aza-2'-deoxycytidine treatment, we identified more than 1000 upregulated genes, 16 of which were upregulated > or =3-fold. Most of them were not known to be silenced by methylation in MCL. A low expression of ING1, RUNX3 and BNIP3L was observed in three of the five the MCL cell lines. In addition, the expression of PARG1, which is located in the frequently deleted region 1p22.1, was substantially reduced and displayed at least partial promoter methylation in all investigated MCL cell lines as well as in 31 primary MCL cases.

INTERPRETATION AND

CONCLUSIONS

In summary, we identified interesting novel candidate genes that probably contribute to the progression of MCL and suggest that PARG1 is a strong candidate tumor suppressor gene in MCL.

Для цитирования: Ripperger Tim, von Neuhoff Nils, Kamphues Kathrin, Emura Makito, Lehmann Ulrich, Tauscher Marcel, Schraders Margit, Groenen Patricia, Skawran Britta, Rudolph Cornelia, Callet-Bauchu Evelyne, van Krieken Johan H J M, Schlegelberger Brigitte, Steinemann Doris. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.. Haematologica. 2007. DOI: 10.3324/haematol.10337.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.